AllSquare Wealth Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-109
Closed -$11K 477
2019
Q3
$11K Sell
109
-350
-76% -$33.3K 0.01% 317
2019
Q2
$42K Hold
459
0.03% 210
2019
Q1
$43K Sell
459
-1,400
-75% -$122K 0.03% 210
2018
Q4
$119K Sell
1,859
-250
-12% -$18.5K 0.1% 100
2018
Q3
$189K Sell
2,109
-100
-5% -$8.84K 0.14% 82
2018
Q2
$175K Buy
2,209
+9
+0.4% +$747 0.13% 85
2018
Q1
$196K Sell
2,200
-246
-10% -$23.6K 0.16% 74
2017
Q4
$255K Buy
2,446
+50
+2% +$5.64K 0.2% 59
2017
Q3
$349K Sell
2,396
-550
-19% -$74.9K 0.29% 45
2017
Q2
$383K Sell
2,946
-100
-3% -$12.3K 0.39% 30
2017
Q1
$379K Hold
3,046
0.33% 41
2016
Q4
$353K Hold
3,046
0.32% 41
2016
Q3
$318K Buy
3,046
+100
+3% +$10.8K 0.31% 40
2016
Q2
$291K Sell
2,946
-422
-13% -$43.7K 0.29% 39
2016
Q1
$337K Buy
3,368
+350
+12% +$36K 0.33% 37
2015
Q4
$361K Buy
3,018
+200
+7% +$23.1K 0.36% 33
2015
Q3
$305K Sell
2,818
-100
-3% -$12.4K 0.31% 31
2015
Q2
$338K Hold
2,918
0.32% 33
2015
Q1
$336K Sell
2,918
-200
-6% -$23.9K 0.32% 31
2014
Q4
$349K Buy
+3,118
New +$329K 0.34% 31

Other funds holding CELG

AllSquare Wealth Management's CELG Position: Q4 2019 in Review

AllSquare Wealth Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 109 shares — an estimated $11K sold.

AllSquare Wealth Management first reported a position in CELG in Q4 2014 and held it in 20 quarters. The position peaked at $383K in Q2 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • AllSquare Wealth Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • AllSquare Wealth Management sold 109 Celgene Corp shares in Q4 2019, an estimated $11K.
  • AllSquare Wealth Management first reported a position in Celgene Corp in Q4 2014 and held it in 20 quarters.
  • AllSquare Wealth Management's Celgene Corp position peaked at $383K in Q2 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on AllSquare Wealth Management's 13F filing for Q4 2019, filed 4 Feb 2020.